CAS: 301673-16-5 - 1-Boc-3-hydroxymethylpiperazine
Formula:C10H20N2O3
InChI:InChI=1/C10H20N2O3/c1-10(2,3)15-9(14)12-5-4-11-8(6-12)7-13/h8,11,13H,4-7H2,1-3H3
- Synonyms:
- tert-Butyl 3-(hydroxymethyl)piperazine-1-carboxylate
- 1-Boc-3-Hydroxymethyl-piperazine
- 4-N-Boc-2-hydroxymethylpiperazine
- 3-Hydroxymethyl-Piperazine-1-Carboxylic Acid Tert-Butyl Ester
1-(tert-Butoxycarbonyl)-3-(hydroxymethyl)piperazine
CAS:301673-16-5
Formula:
C10H20N2O3
Purity:
>98.0%(GC)(T)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
216.28
Ref: 3B-B4716
200mg | 88.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
1-Boc-3-hydroxymethylpiperazine
CAS:301673-16-5
Formula:
C10H20N2O3
Purity:
95%
Color and Shape:
Solid
Molecular weight:
216.2774
Ref: IN-DA0038TX
1g | 25.00 € | ||
5g | 52.00 € | ||
10g | 69.00 € | ||
25g | 114.00 € | ||
50g | 159.00 € | ||
100g | 318.00 € | ||
250mg | 22.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
4-N-Boc-2-Hydroxymethylpiperazine
CAS:301673-16-5
Purity:
97.0%
Color and Shape:
Solid
Molecular weight:
216.281005859375
Ref: 10-F040657
1g | 20.00 € | ||
5g | 31.00 € | ||
10g | 54.00 € | ||
25g | 91.00 € | ||
100g | 325.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
3-(Hydroxymethyl)piperazine, N1-BOC protected
CAS:301673-16-5
Formula:
C10H20N2O3
Purity:
97%
Color and Shape:
pale yellow solid
Molecular weight:
216.28g/mol
Ref: 54-OR61341
1g | 49.00 € | ||
5g | 119.00 € | ||
10g | 176.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
tert-Butyl 3-(hydroxymethyl)piperazine-1-carboxylate
CAS:301673-16-5
Please enquire for more information about tert-Butyl 3-(hydroxymethyl)piperazine-1-carboxylate including the price, delivery time and more …
Formula:
C10H20N2O3
Purity:
Min. 95%
Molecular weight:
216.28 g/mol
Ref: 3D-FB139852
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
500mg | Discontinued | Request information |